MEERA CLINICALTRIALLINK
Live / Applied — Third extension granted (statement of use) (as of 31 Aug 2025)
What this means for you
Not registered yet, but its 01 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97817528
- Mark type
- Stylized text
- Filed
- 01 Mar 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Stephen Prince
Goods and services
- Class 035 — Advertising and business services: Medical practice management for others in the field of medical clinical trials by creating and managing appointments, documenting visit notes, oversight of enrolled patients, and patient recruitment and advertising campaigns
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for connecting stakeholders, namely, clinical research organizations, patients, trial clinic sites, and primary care physicians, for clinical trials to improve recruitment and retention, data collection, and analytics
Owner
- Meera Therapeutics, Inc, La Verne, CA, US
- Meera Therapeutics, Inc, La Verne, CA, US
Prosecution history
- 17 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Aug 2025 — SOU EXTENSION 3 GRANTED
- 31 Aug 2025 — SOU EXTENSION 3 FILED
- 31 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 2 GRANTED
- 04 Mar 2025 — SOU EXTENSION 2 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2024 — SOU EXTENSION 1 GRANTED
- 23 Aug 2024 — SOU EXTENSION 1 FILED
- 23 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED